Bio-Path Holdings, Inc. (BPTH)
0.0005
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Bio-Path Holdings Net Income (Quarterly) : -2.636M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.636M |
| March 31, 2026 | -0.27M |
| December 31, 2025 | -0.249M |
| September 30, 2025 | -0.976M |
| June 30, 2025 | -4.597M |
| March 31, 2025 | -2.852M |
| December 31, 2024 | -2.753M |
| September 30, 2024 | -2.115M |
| June 30, 2024 | -1.869M |
| March 31, 2024 | -3.157M |
| December 31, 2023 | -3.372M |
| September 30, 2023 | -3.199M |
| June 30, 2023 | -4.234M |
| March 31, 2023 | -5.273M |
| December 31, 2022 | -3.966M |
| September 30, 2022 | -3.535M |
| June 30, 2022 | -3.008M |
| March 31, 2022 | -3.359M |
| December 31, 2021 | -4.116M |
| September 30, 2021 | -2.069M |
| June 30, 2021 | -1.808M |
| March 31, 2021 | -2.447M |
| December 31, 2020 | -2.55M |
| September 30, 2020 | -2.968M |
| June 30, 2020 | -2.04M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.324M |
| December 31, 2019 | -2.389M |
| September 30, 2019 | -2.242M |
| June 30, 2019 | -2.456M |
| March 31, 2019 | -1.512M |
| December 31, 2018 | -1.909M |
| September 30, 2018 | -3.081M |
| June 30, 2018 | -1.677M |
| March 31, 2018 | -1.916M |
| December 31, 2017 | -2.167M |
| September 30, 2017 | -2.474M |
| June 30, 2017 | -1.985M |
| March 31, 2017 | -0.397M |
| December 31, 2016 | -1.371M |
| September 30, 2016 | -1.57M |
| June 30, 2016 | -1.942M |
| March 31, 2016 | -1.867M |
| December 31, 2015 | -1.459M |
| September 30, 2015 | -1.508M |
| June 30, 2015 | -1.126M |
| March 31, 2015 | -1.375M |
| December 31, 2014 | -1.598M |
| September 30, 2014 | -1.148M |
| June 30, 2014 | -1.269M |
| March 31, 2014 | -0.5049M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Yulong Eco-Materials Ltd. | -0.0483M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Athersys, Inc. | -- |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.636M |
| EPS Diluted (Quarterly) | -0.0875 |
| Enterprise Value | 0.5441M |
| Earnings Yield | -51.56K% |
| Normalized Earnings Yield | -36160.00 |